Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83201-83250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05523128
The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.
NARecruiting
6 participants
Started: Sep 29, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05496855
Remote Care in People With Rheumatoid Arthritis
NAActive, not recruiting
228 participants
Started: Sep 29, 2022 · Completed: Oct 14, 2028
1 condition1 sponsor1 location
NCT05556473
F-Tryptophan PET/CT in Human Cancers
PHASE1Recruiting
24 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT05525962
Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.
N/ARecruiting
300 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
8 conditions1 sponsor5 locations
NCT05541653
The IGNITE Study on Concentrated Investment in Black Neighborhoods
NAActive, not recruiting
571 participants
Started: Sep 29, 2022 · Completed: Jun 30, 2026
6 conditions1 sponsor1 location
NCT05599581
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
NAActive, not recruiting
1,562 participants
Started: Sep 29, 2022 · Completed: Jul 31, 2026
3 conditions3 sponsors2 locations
NCT06509763
ElectrocardioGraphic Imaging During Left bUndle Branch Implant to valiDate Ecg Criteria
NAActive, not recruiting
50 participants
Started: Sep 29, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05084248
Vitamin D Deficiency in Adults Following a Major Burn Injury
PHASE4Recruiting
70 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06315686
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA
PHASE2Recruiting
20 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05067764
Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
NARecruiting
172 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2029
1 condition1 sponsor2 locations
NCT05564689
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
N/ARecruiting
60 participants
Started: Sep 29, 2022 · Completed: Sep 30, 2026
4 conditions1 sponsor1 location
NCT05734222
Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias
NARecruiting
110 participants
Started: Sep 29, 2022 · Completed: May 23, 2025
3 conditions1 sponsor1 location
NCT05424263
Acetate and Age-associated Arterial Dysfunction
PHASE2Recruiting
66 participants
Started: Sep 29, 2022 · Completed: Sep 1, 2025
3 conditions1 sponsor1 location
NCT05521412
EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05482971
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
PHASE2Active, not recruiting
91 participants
Started: Sep 29, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor34 locations
NCT05699460
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
N/AActive, not recruiting
150 participants
Started: Sep 29, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor11 locations
NCT05574244
Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction
NARecruiting
336 participants
Started: Sep 29, 2022 · Completed: Mar 31, 2029
1 condition1 sponsor18 locations
NCT04169451
IUI With Letrozole Versus in Natural Cycle
NARecruiting
982 participants
Started: Sep 29, 2022 · Completed: Jun 30, 2026
2 conditions5 sponsors1 location
NCT05909800
Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.
PHASE2Recruiting
102 participants
Started: Sep 29, 2022 · Completed: Jul 31, 2024
1 condition2 sponsors2 locations
NCT05543993
COVID Booster in Pregnancy and Lactation
N/ARecruiting
200 participants
Started: Sep 29, 2022 · Completed: Mar 1, 2025
1 condition3 sponsors1 location
NCT05771168
Surgery for Male Stress Urinary Incontinence
N/ARecruiting
138 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
1 condition1 sponsor1 location
NCT05414344
A Brief Intervention for Alcohol Users With Interpersonal Trauma
NARecruiting
225 participants
Started: Sep 29, 2022 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT05219110
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
NARecruiting
1,040 participants
Started: Sep 29, 2022 · Completed: Aug 31, 2027
2 conditions27 sponsors26 locations
NCT05421143
Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
N/ARecruiting
240 participants
Started: Sep 29, 2022 · Completed: Apr 30, 2027
1 condition3 sponsors1 location
NCT05635747
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
N/AEnrolling by invitation
32 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
2 conditions2 sponsors1 location
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
PHASE3Recruiting
409 participants
Started: Sep 29, 2022 · Completed: Sep 30, 2031
2 conditions4 sponsors42 locations
NCT05491616
Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study
PHASE2Active, not recruiting
77 participants
Started: Sep 29, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05564078
IL-13 Blockade and Airway Autoimmunity in Asthma
N/ARecruiting
50 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05382169
Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders
N/ARecruiting
30 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05302934
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
N/ARecruiting
600 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2027
6 conditions1 sponsor4 locations
NCT05587569
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
NARecruiting
80 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor9 locations
NCT05562791
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
PHASE1Recruiting
20 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05544864
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NARecruiting
376 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2026
2 conditions4 sponsors5 locations
NCT05304039
Phenotyping and Classifying Asthma Exacerbations
N/AActive, not recruiting
200 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05556733
FMT for Post-acute COVID-19 Syndrome
NAActive, not recruiting
60 participants
Started: Sep 28, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT05378035
DOAC in Chinese Patients With Atrial Fibrillation
N/ARecruiting
427 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2027
7 conditions1 sponsor1 location
NCT05639426
Preventing Youth Violence Through Building Equitable Communities
NAEnrolling by invitation
1,672 participants
Started: Sep 28, 2022 · Completed: May 15, 2027
2 conditions3 sponsors1 location
NCT05532722
ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
PHASE1/PHASE2Active, not recruiting
21 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor8 locations
NCT05415397
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
PHASE3Recruiting
140 participants
Started: Sep 28, 2022 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT04440501
Virtual Reality to Teach, Improve Outcomes, and Engage (VIRTUE): Virtual Reality to Improve Gluten-Free Diet Knowledge in Pediatric Celiac Disease
NANot yet recruiting
100 participants
Started: Sep 28, 2022 · Completed: Jan 28, 2026
1 condition1 sponsor0 locations
NCT05546567
NOPARK Open Label Extension Study
NAActive, not recruiting
400 participants
Started: Sep 28, 2022 · Completed: Jun 20, 2025
1 condition1 sponsor1 location
NCT05417776
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
PHASE2Recruiting
30 participants
Started: Sep 28, 2022 · Completed: Apr 1, 2026
1 condition2 sponsors1 location
NCT05421286
The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events
N/AActive, not recruiting
991 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors22 locations
NCT05918549
Movement Analysis in Musculoskeletal Oncology: a Pilot Study
N/ARecruiting
30 participants
Started: Sep 28, 2022 · Completed: Sep 28, 2024
1 condition3 sponsors1 location
NCT05578807
Total Tubeless Percutaneous Nephrolithotomy Without a Ureteral Catheter
NARecruiting
100 participants
Started: Sep 28, 2022 · Completed: Jan 10, 2025
2 conditions1 sponsor1 location
NCT05427240
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
NARecruiting
1,000 participants
Started: Sep 28, 2022 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT05660811
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
PHASE4Recruiting
80 participants
Started: Sep 28, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05670301
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
NARecruiting
2,500 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2029
3 conditions6 sponsors7 locations
NCT05568953
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
PHASE2Recruiting
70 participants
Started: Sep 28, 2022 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT05456685
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
PHASE2Active, not recruiting
125 participants
Started: Sep 28, 2022 · Completed: Nov 30, 2026
3 conditions1 sponsor69 locations